Correspondence 0001477932-24-003284 from Quantum Genesis AI Corp. (QTZM)
Quantum Genesis AI Corp.
Date: May 24, 2024 · CIK: 0001663038 · Accession: 0001477932-24-003284
AI Filing Summary & Sentiment
File numbers found in text: 024-12403
Letter
United States Securities & Exchange Commission Division of Corporate Finance – Office of Real Estate & Construction QUANTUMZYME CORP. (the “Company”) Offering Statement 1-A/A Filed: May 13, 2024 File No. 024-12403
Re:
Dear Sir or Madam:
We respectfully request that the Commission qualify the Offering on or before 2pm EST, May 29, 2024, and agree that:
On behalf of the Company, the undersigned: (i) confirms that at least one state has advised the Company that it is prepared to qualify the offering, and (ii) acknowledges that:
1. Should the Commission or the Staff, acting pursuant to delegated authority, declare the filing of the Offering Statement qualified, it does not foreclose the Commission from taking any action with respect to the filing;
2. The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing qualified, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
3. We do not require FINRA to approve any of our compensation agreements, as we are self-underwriting and not engaging any third parties to assist in the sale or marketing of this Offering. Note, the management fee that the Company receives upon the sale of any real estate does not require us to register as a broker/dealer or an investment adviser under the 1940 Act or any other applicable state statute; and
4. The Company may not assert Staff comments and the declaration of qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions or comments regarding the foregoing, please do not hesitate to contact the undersigned via email at naveen@quantumzymecorp.com.
By: /s/ Naveen Kulkarni
Name: Naveen Kulkarni
Title: CEO
Show Raw Text
CORRESP 1 filename1.htm qtzm_corresp.htmQUANTUMZYME CORP. May 24, 2024 United States Securities & Exchange Commission Division of Corporate Finance – Office of Real Estate & Construction Washington, DC 20549 Re: QUANTUMZYME CORP. (the “Company”) Offering Statement 1-A/A Filed: May 13, 2024 File No. 024-12403 Dear Sir or Madam: We respectfully request that the Commission qualify the Offering on or before 2pm EST, May 29, 2024, and agree that: On behalf of the Company, the undersigned: (i) confirms that at least one state has advised the Company that it is prepared to qualify the offering, and (ii) acknowledges that: 1. Should the Commission or the Staff, acting pursuant to delegated authority, declare the filing of the Offering Statement qualified, it does not foreclose the Commission from taking any action with respect to the filing; 2. The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing qualified, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and 3. We do not require FINRA to approve any of our compensation agreements, as we are self-underwriting and not engaging any third parties to assist in the sale or marketing of this Offering. Note, the management fee that the Company receives upon the sale of any real estate does not require us to register as a broker/dealer or an investment adviser under the 1940 Act or any other applicable state statute; and 4. The Company may not assert Staff comments and the declaration of qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. If you have any questions or comments regarding the foregoing, please do not hesitate to contact the undersigned via email at naveen@quantumzymecorp.com. By: /s/ Naveen Kulkarni Name: Naveen Kulkarni Title: CEO